These independent CME/CE activities are supported by educational grants from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.



   Mastery of Medicine in
  Diabetes
  Management
  1. Course List
CME/CE Information

Target Audience

Primary care physicians, diabetologists, endocrinologists, nurse practitioners, physician assistants, nurses, pharmacists, and other healthcare professionals involved in the screening, treatment and management of patients with diabetes.

Activity Goal

The goal of this initiative is to provide monthly touchpoints so that clinicians have a comprehensive and up-to-date understanding of the best practices in diabetes management. This includes practical case-based learnings, interactive video, published and peer-reviewed articles, and appropriate news coverage on diabetes management. Designed to provide timely, scientific data that can be applied directly to the clinical settings for in-the-trenches clinicians.

Learning Objective (s)

  • Describe the importance of early diagnosis of diabetes and pathophysiologic mechanisms that may serve as targets for therapy.
  • Evaluate the link between cardiovascular disease and diabetes and the impact of treatment on cardiovascular outcomes.
  • Formulate personalized and guideline-based treatment strategies based on mechanism of action as well as efficacy and safety profiles of current and emerging monotherapies and combination agents.
  • Develop and implement methods for shared decision-making that reflect consideration of the individual patient to maximize treatment adherence, patient outcomes, and quality of life.


CME Information: Physicians


Statement of Accreditation

Projects In Knowledge® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

Projects In Knowledge® designates this enduring material for a maximum of 12.5 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CE Information: Nurses

Specific credit information can be found on each activity's web page.

CME/CE Instructions


To obtain CME/CE credit:

  1. Read or listen to each activity carefully.
  2. Complete/submit each posttest and evaluation.
  3. Instantly access and print out your certificate.

There is no fee for this activity.

CONTRACT FOR MUTUAL RESPONSIBILITY IN CME/CE

Projects In Knowledge has developed the contract to demonstrate our commitment to providing the highest quality professional education to clinicians, and to help clinicians set educational goals to challenge and enhance their learning experience.

For more information on the contract, click here.
Disclosure Information

The Disclosure Policy of Projects In Knowledge® requires that all those who have control of content comply with the Standards for Commercial Support. Faculty, planners, PIK editorial scientific team, reviewers, and medical writers are required to disclose any personal interest or relationship they or their spouse/partner have with the supporters of this activity or any commercial interest that is discussed in their presentation. Any discussions of unlabeled/unapproved uses of drugs or devices will also be disclosed during the presentations.

Vivian A. Fonseca, MD, FRCP has received honoraria from Abbott Laboratories, Amgen, Astra Zeneca, Boehringer Ingelheim, Eli Lilly and Company, Janssen Pharmaceuticals, Inc., Novo Nordisk, Inc, Pamlabs, Sanofi-aventis, and Takeda Pharmaceuticals; and has conducted contracted research for Abbott Laboratories, Asahi Kasei Pharma Corp., Eli Lilly and Company, Endo Barrier, Gilead Sciences, and Novo Nordisk, Inc.

Hirva A. Bakeri, MD, MS has no relevant relationships to disclose.

Erjola Balliu, MD has no relevant relationships to disclose.

Carolina R. Hurtado, MD has no relevant relationships to disclose.

Silvio E. Inzucchi, MD has received consulting fees from Alere, Janssen Pharmaceuticals, and vTv Therapeutics; and has served on committees or data monitoring boards for Astra Zeneca, Boehringer Ingelheim, Daiichi, Eisai, Intarcia, Lexicon Pharmaceuticals, Inc., Novo Nordisk, Sankyo, and Sanofi.

Laura M. Jacobsen, MD

Carol J. Levy, MD, CDE

David M. Nathan, MD has disclosed no relevant relationships.

Anne L. Peters, MD has received salary/honoraria from AstraZeneca/Bristol-Myers Squibb and Novo Nordisk Pharmaceuticals, Inc.; and consulting fees from Abbott Diabetes Care, AstraZeneca/Bristol-Myers Squibb, Becton, Dickinson and Company, Boehringer Ingelheim, Eli Lilly and Company, Janssen Pharmaceuticals, Medtronic MiniMed, Inc., Sanofi-Aventis, and Takeda Pharmaceutical Company Limited.

Desmond A. Schatz, MD has received consulting fees from sanofi.

Nina Suda, MD has no relevant relationships to disclose.

Tina K. Thethi, MD, MPH, FACE

Peer Reviewer has disclosed no relevant relationships.

Dorothy Caputo, MA, BSN, RN (lead nurse planner) has no relevant relationships to disclose.
Bernadette Marie Makar, MSN, NP-C, APRN-C (nurse planner) has no relevant relationships to disclose.

Projects In Knowledge's staff members have no relevant relationships to disclose.

These activities may contain discussions of unlabeled/unapproved uses of drugs or devices. Specific product disclosure will be forthcoming in each activity.

The opinions expressed in these activities are those of the faculty and do not necessarily reflect those of Projects In Knowledge.

This CME/CE activity is provided solely as an educational service. Specific patient care decisions are the responsibility of the clinician caring for the patient.

These independent CME/CE activities are supported by educational grants from Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.

2311